Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Welcome to the agenda for the 2013 MassDevice Big 100 West. All the pertinent event information logistics and updates will be hosted here.

If this is your first event, please take note that our program is rather unique. Our program is split into three portions.

First, we have educational sessions from 4:00-5:30. We call these our "Sparking the Conversation" sessions. These are generally panel discussions on hot button issues that med tech companies are facing, featuring executives and experts in each particular discipline. These sessions are concurrent, so you’ll have to pick one.

Second, we have a networking mixer with food and drinks so you can connect and re-connect with friends in the industry.

Finally, we have our main event featuring our CEO interviews. On December 10th we’ll hear from Dr. Robert Greenberg on the amazing rise of the "bionic eye," followed by a fascinating panel on the future of chronic diseases featuring C-level executives from ResMed, St. Jude Medical and Glooko. You can find information below on all those panels.

That’s all we have for now. Please make sure to reach out to the people you want to connect with and, as always, you can contact me with any questions.

Brian
View analytic
avatar for David  Dykeman

David Dykeman

Greenberg Traurig
Shareholder
Boston, MA

David Dykeman, who co-chairs the firm's global Life Sciences & Medical Technology group, is a registered patent attorney with nearly 20 years of experience in patent and intellectual property law. David's practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, nanotechnology, and information technology.


David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities.


An author of over 45 articles and a speaker at over 40 conferences on intellectual property law, David is the founding co-chair of the ABA’s Medical Devices Committee. He was honored as one of Boston's "40 Under 40" innovative business leaders by the Boston Business Journal and was named to the "40 Medtech Innovators Under 40" list by Medical Device & Diagnostic Industry (MD+DI) Magazine. David has also been named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.